Cesarean Section ComplicationsNCT06008964
The Effect of Aromatherapy Applied After Cesarean Section on Pain Intensity and Comfort Level
A study testing Ylang Ylang oil with inhalation, Lavender oil with inhalation and SALINE SOLUTION WİTH INHALITION in people with Cesarean Section Complications, run by KTO Karatay University at 1 site in Turkey (Türkiye).
Trial summary
Today, many complementary therapies such as acupuncture, reflexology, homeopathy, hypnotherapy, music and aromatherapy are tried in addition to medical methods to reduce pain and anxiety. Aromatherapy is a therapy method in which essential oils are used to protect and improve physical and psychological health. Read more about this study
- Who is it for?
- Ages 18 to 49 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Cesarean Section Complications
- What is being tested?
- Ylang Ylang oil with inhalation, Lavender oil with inhalation and SALINE SOLUTION WİTH INHALITION
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 75 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Jun 2023to 25 Oct 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 49 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Women aged 18-49 years.
- Having undergone caesarean section under spinal anesthesia.
- Having had an uncomplicated term delivery.
- Being at the fourth postoperative hour before the first study intervention.
- Reporting a resting pain score of ≥4 on the Visual Analog Scale (VAS).
- Having no known allergy to lavender or ylang-ylang essential oils.
- Voluntarily agreeing to participate and providing written informed consent.
Who cannot join
- epilepsy,
- migraine,
- chronic headache,
- asthma,
- women who are allergic to fragrance sensitivities to aromatic oils
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Determination of the Effect of Aromatherapy Using Lavender and Ylang Ylang Essential Oils on Pain Severity and Comfort Level After Cesarean Section: A Randomized Controlled Study
Today, many complementary therapies such as acupuncture, reflexology, homeopathy, hypnotherapy, music and aromatherapy are tried in addition to medical methods to reduce pain and anxiety. Aromatherapy is a therapy method in which essential oils are used to protect and improve physical and psychological health. Oils can be applied directly to a single person or indirectly to people in a room by inhalation . In direct application without steam, essential oils can be applied by inhalation by dripping onto a cotton ball . It is stated that lavender aromatherapy, one of the most commonly used aromatherapies, has analgesic, antiseptic, sedative, antispasmodic and healing properties Ylang Ylang aromatherapy is stated analgesic, anti-inflammatory, antimicrobial, antiemetic,anti-tarral, carminative, sedative, antiseptic, spasmolytic properties. In the studies conducted, anxiety, labor pain, labor duration, and psychological effects of aromatherapy were examined, but no study was found in which lavender and ylang-ylang essential oils were used and the effects of pain and comfort level were examined. The aim of this study is to determine the effect of lavender and Ylang Ylang essential oils in relieving pain and increasing comfort after cesarean section.
- Conditions
- Cesarean Section Complications
- Being tested
- Ylang Ylang oil with inhalation, Lavender oil with inhalation, SALINE SOLUTION WİTH INHALITION
- Keywords
- Aromatherapy, pain, ceserean
- Medical subject headings
- Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ylang Ylang oil with inhalationOther
Ylang Ylang OIL WILL BE INHALED
Lavender oil with inhalationOther
LAVENDER OIL WILL BE INHALED
SALINE SOLUTION WİTH INHALITIONOther
SALINE SOLUTION WILL BE INHALED
| Study group | Role | What they receive |
|---|---|---|
| Ylang Ylang oil Group | Active comparator | GROUP 1 Receives: Other: Ylang Ylang oil with inhalation |
| Control Group | Placebo comparator | SALINE SOLUTION Receives: Other: SALINE SOLUTION WİTH INHALITION |
| Lavender oil | Active comparator | GROUP 2 Receives: Other: Lavender oil with inhalation |
What is being measured
The primary outcome is the main question the study is designed to answer.
pain related to cesarean section
It will be measured with Visual Analog Scale. Visual Analog Scale has a rating between 0-10. The higher the score, the greater the pain.
Measured: Baseline at 4 hours postoperatively, before the first intervention, and 30 minutes after completion of the third intervention administered at 12 hours postoperatively.
Secondary outcomes (1)
comfort related to cesarean section
Comfort will be measured with the postpartum comfort scale. The higher the score, the higher the comfort level.
Measured: Baseline at 4 hours postoperatively, before the first intervention, and 30 minutes after completion of the third intervention administered at 12 hours postoperatively.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Aug 2023
- Study start15 Jun 2023
- Primary completion17 Aug 2023
- Study completion25 Oct 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cesarean Section ComplicationsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 75 participants (actual)
Sponsor and investigators
- Lead sponsor
- KTO Karatay University
- Sponsor type
- University, hospital or other
- Collaborators
- Şerife İrem DÖNER, Merve YAZAR, JULE ERİÇ HORASANLI
- Responsible party
- Principal investigator, Hafize Dağ Tüzmen, KTO Karatay University
- Investigators
- şerife irem döner, Study chair, serifeiremdoner@gmail.comMerve Yazar, Study chair, merve.yazar@karatay.edu.tr
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06008964
- Sponsor's protocol ID
- Aromatherapy Group
- Status last verified
- Oct 2026
- First submitted
- 18 Apr 2023
- Last updated
- 2 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 2 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Determination of the Effect of Aromatherapy Using Lavender and Ylang Ylang Essential Oils on Pain Severity and Comfort Level After Cesarean Section: A Randomized Controlled Study
- ClinicalTrials.gov ID
- NCT06008964
- Acronym / sponsor ID
- Aromatherapy Group
- Conditions
- Cesarean Section Complications
- Keywords
- Aromatherapy, pain, ceserean
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 75 participants (actual)
- Lead sponsor
- KTO Karatay UniversityUniversity, hospital or other
- Collaborators
- Şerife İrem DÖNER, Merve YAZAR, JULE ERİÇ HORASANLI
- Study start
- 15 Jun 2023 (actual)
- Primary completion
- 17 Aug 2023 (actual)
- Study completion
- 25 Oct 2023 (actual)
- First posted
- 24 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Today, many complementary therapies such as acupuncture, reflexology, homeopathy, hypnotherapy, music and aromatherapy are tried in addition to medical methods to reduce pain and anxiety. Aromatherapy is a therapy method in which essential oils are used to protect and improve physical and psychological health. Oils can be applied directly to a single person or indirectly to people in a room by inhalation . In direct application without steam, essential oils can be applied by inhalation by dripping onto a cotton ball . It is stated that lavender aromatherapy, one of the most commonly used aromatherapies, has analgesic, antiseptic, sedative, antispasmodic and healing properties Ylang Ylang aromatherapy is stated analgesic, anti-inflammatory, antimicrobial, antiemetic,anti-tarral, carminative, sedative, antiseptic, spasmolytic properties. In the studies conducted, anxiety, labor pain, labor duration, and psychological effects of aromatherapy were examined, but no study was found in which lavender and ylang-ylang essential oils were used and the effects of pain and comfort level were examined. The aim of this study is to determine the effect of lavender and Ylang Ylang essential oils in relieving pain and increasing comfort after cesarean section.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Ylang Ylang oil Group | Active comparator | Other: Ylang Ylang oil with inhalationGROUP 1 |
| Control Group | Placebo comparator | Other: SALINE SOLUTION WİTH INHALITIONSALINE SOLUTION |
| Lavender oil | Active comparator | Other: Lavender oil with inhalationGROUP 2 |
Who may qualify
- Ages
- 18 to 49 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Women aged 18-49 years.
- Having undergone caesarean section under spinal anesthesia.
- Having had an uncomplicated term delivery.
- Being at the fourth postoperative hour before the first study intervention.
- Reporting a resting pain score of ≥4 on the Visual Analog Scale (VAS).
Key exclusion criteria (5 listed)
- epilepsy,
- migraine,
- chronic headache,
- asthma,
- women who are allergic to fragrance sensitivities to aromatic oils
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ylang Ylang oil with inhalationYlang Ylang OIL WILL BE INHALED | Other | Ylang Ylang oil Group |
| Lavender oil with inhalationLAVENDER OIL WILL BE INHALED | Other | Lavender oil |
| SALINE SOLUTION WİTH INHALITIONSALINE SOLUTION WILL BE INHALED | Other | Control Group |
Primary outcome
pain related to cesarean section
Time frame: Baseline at 4 hours postoperatively, before the first intervention, and 30 minutes after completion of the third intervention administered at 12 hours postoperatively.
It will be measured with Visual Analog Scale. Visual Analog Scale has a rating between 0-10. The higher the score, the greater the pain.
1 secondary outcome
comfort related to cesarean section
Time frame: Baseline at 4 hours postoperatively, before the first intervention, and 30 minutes after completion of the third intervention administered at 12 hours postoperatively.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Nov 2026.
- Individual participant dataSharing planned: Yes
Related trials for Cesarean Section Complications
Not yet recruiting
Comparison of Effect of Two Different Doses of Intravenous Oxytocin on Patients Undergoing Elective Cesarean Section
Postpartum Hemorrhage, Uterine Atony
Not yet recruitingObservational study
Ultrasound Assessment Of Gastric Volume In Pregnant Women Undergoing Elective Cesarean Section
Gestational Diabetes Mellitus (GDM), Obstetric Anesthesia
RecruitingPhase 1
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
Pain, Postpartum Depression
Recruiting
Clinical Impact of Uterine Repair During Cesarean Section With Barbed Suture on the Incidence of Isthmocele
Isthmocele, Cesarean Scar Defect
Not yet recruiting
The Mepilex Cesarean Delivery Trial / MEPIDEL
Surgical Site Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
şerife irem döner study chair
serifeiremdoner@gmail.com
Merve Yazar study chair
merve.yazar@karatay.edu.tr
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Ylang Ylang oil with inhalation, Lavender oil with inhalation and SALINE SOLUTION WİTH INHALITION in people with Cesarean Section Complications, run by KTO Karatay University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
pain related to cesarean section (time frame: Baseline at 4 hours postoperatively, before the first intervention, and 30 minutes after completion of the third intervention administered at 12 hours postoperatively.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.